logo
Can Mixed Fundamentals Have A Negative Impact on Haleon plc (LON:HLN) Current Share Price Momentum?

Can Mixed Fundamentals Have A Negative Impact on Haleon plc (LON:HLN) Current Share Price Momentum?

Yahoo08-05-2025

Most readers would already be aware that Haleon's (LON:HLN) stock increased significantly by 13% over the past month. However, we decided to pay attention to the company's fundamentals which don't appear to give a clear sign about the company's financial health. Specifically, we decided to study Haleon's ROE in this article.
Return on equity or ROE is a key measure used to assess how efficiently a company's management is utilizing the company's capital. Simply put, it is used to assess the profitability of a company in relation to its equity capital.
AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.
How Is ROE Calculated?
ROE can be calculated by using the formula:
Return on Equity = Net Profit (from continuing operations) ÷ Shareholders' Equity
So, based on the above formula, the ROE for Haleon is:
9.1% = UK£1.5b ÷ UK£16b (Based on the trailing twelve months to December 2024).
The 'return' is the income the business earned over the last year. One way to conceptualize this is that for each £1 of shareholders' capital it has, the company made £0.09 in profit.
View our latest analysis for Haleon
What Has ROE Got To Do With Earnings Growth?
So far, we've learned that ROE is a measure of a company's profitability. Depending on how much of these profits the company reinvests or "retains", and how effectively it does so, we are then able to assess a company's earnings growth potential. Assuming all else is equal, companies that have both a higher return on equity and higher profit retention are usually the ones that have a higher growth rate when compared to companies that don't have the same features.
Haleon's Earnings Growth And 9.1% ROE
On the face of it, Haleon's ROE is not much to talk about. We then compared the company's ROE to the broader industry and were disappointed to see that the ROE is lower than the industry average of 12%. Accordingly, Haleon's low net income growth of 3.7% over the past five years can possibly be explained by the low ROE amongst other factors.
We then compared Haleon's net income growth with the industry and found that the company's growth figure is lower than the average industry growth rate of 7.7% in the same 5-year period, which is a bit concerning.
LSE:HLN Past Earnings Growth May 8th 2025
The basis for attaching value to a company is, to a great extent, tied to its earnings growth. The investor should try to establish if the expected growth or decline in earnings, whichever the case may be, is priced in. By doing so, they will have an idea if the stock is headed into clear blue waters or if swampy waters await. Has the market priced in the future outlook for HLN? You can find out in our latest intrinsic value infographic research report.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Only 0.4% of design job listings are asking for expertise in these popular AI tools
Only 0.4% of design job listings are asking for expertise in these popular AI tools

Fast Company

time15 minutes ago

  • Fast Company

Only 0.4% of design job listings are asking for expertise in these popular AI tools

From Shopify and Duolingo to Google and OpenAI, AI-first companies are now defining our era. And just about every designer Fast Company has talked to for the past three years has shifted from a deep-seated fear of AI to a steady adoption of these AI tools in some part of their workflow. But when analyzing 176,000 design job listings for our upcoming 'Where the Design Jobs Are' report (out June 16), we were struck by a most surprising finding. Only 0.4% of design jobs asked for experience in specific AI tools, including ChatGPT, Dall-E, Midjourney, and Runway. In fact, only 8% of all listings made any mention of AI at all. And even then the term was generally used in marketing speak, the kind that positions a company as being 'AI-powered.' After reaching out to a dozen major companies across industries to figure out why, we heard a somewhat unsatisfying, but also common, refrain: 'We aren't asking for specific proficiencies with AI tools explicitly as part of the hiring process at the moment,' wrote a Figma spokesperson in response to our request. 'That said, we tend to hire people who are curiously exploring and studying new tools that help improve their work . . . [and] it can be helpful to see how candidates get creative with AI, whether via side projects or for their core work.'

UK's Starling Bank rolls out Gen AI powered chatbot
UK's Starling Bank rolls out Gen AI powered chatbot

Yahoo

time16 minutes ago

  • Yahoo

UK's Starling Bank rolls out Gen AI powered chatbot

Starling, a UK digital bank, has launched a new generative AI chatbot named 'Spending Intelligence', integrated within its mobile app. The chatbot is designed to answer customer queries about their spending habits. It is powered by Gemini, Google's LLM, and operates within the Google Cloud Platform, where Starling hosts its tech infrastructure. Spending Intelligence is now available to all Starling customers, including personal and business account holders. The chatbot is accessible via a search bar located at the top of the existing 'spending' section of the app, providing users with insights into their spending patterns across more than 50 customisable categories. The new chatbot builds on this functionality by enabling users to ask questions about their spending during defined timeframes. Spending Intelligence draws only on data from within customers' Starling accounts and does not offer financial advice, such as investment suggestions or savings strategies, due to regulatory boundaries. The feature is free to use and, according to Starling's chief information officer Harriet Rees, there are 'absolutely no plans to make it paid for use', according to This is Money. By analysing the types of questions customers ask, Starling also hopes to identify opportunities for further AI deployment, such as fraud detection and onboarding processes. As part of its agreement with Google, any data received through customer interactions with the chatbot will not be used to train Gemini's LLMs. While future updates may include features such as suggesting ways to save money, for now, the chatbot is focused solely on providing insights into spending. Rees said: 'We're having a think about how you could save. But we genuinely believe giving customers insights about how they are spending is the best way to get them thinking about where they could save.' In April, Starling Bank's Software-as-a-Service (SaaS) division, Engine by Starling, established its first international subsidiary, Engine by Starling Services US. "UK's Starling Bank rolls out Gen AI powered chatbot " was originally created and published by Retail Banker International, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

IQVIA Launches New AI Agents for Life Sciences and Healthcare
IQVIA Launches New AI Agents for Life Sciences and Healthcare

Business Wire

time28 minutes ago

  • Business Wire

IQVIA Launches New AI Agents for Life Sciences and Healthcare

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, unveils AI agents at GTC Paris. IQVIA's new custom-built AI agents using NVIDIA technology are designed to enhance workflows and accelerate insights for life sciences. These live applications of agentic architectures illustrate how IQVIA AI and deep domain expertise are transforming business processes and patient outcomes. 'This is a pivotal opportunity to deliver the precise, efficient workflows and insights required by the modern life sciences industry backed by deep industry expertise and powerful technology partnerships,' said Bhavik Patel, president of IQVIA Commercial Solutions. 'Our collaboration with NVIDIA helps us realize our vision to power smarter healthcare for everyone, everywhere.' While IQVIA Healthcare-grade AI ® has been delivering insights with the precision, speed and trust required for the life sciences industry across the asset life cycle, this recent collaboration with NVIDIA represents an exciting new phase as we advance the powerful future promised by agentic AI in a way that meets the unique needs of life sciences companies. Leveraging NVIDIA NIM Agent Blueprints for rapid development, the NeMo Customizer for fine-tuning, and NeMo Guardrails to safeguard deployment, IQVIA is developing agents that help find breakthroughs and simplify operations across life sciences. Use cases for these agentic offerings include target identification, clinical data review, literature review, market assessment, and HCP engagement. 'Every moment counts when planning clinical trials, from discovery to commercial application,' said Kimberly Powell, vice president of healthcare, NVIDIA. 'Working with industry leaders like IQVIA, we can build domain-specific agents that can demonstrate efficiency and precision. One example is Agentic AI helping researchers sift through literature reviews, allowing IQVIA's thousands of customers the potential to benefit from our collaboration.' IQVIA announced a strategic collaboration with NVIDIA in January to build custom foundation models and agentic AI workflows to accelerate research, clinical development and access to new treatments. AI applications trained on IQVIA's vast healthcare-specific information will help the industry enhance, streamline, and focus clinical trials and commercial launches with powerful workflow coordination and insights. Following NVIDIA GTC Paris, learn more about the future of life sciences at IQVIA TechIQ 2025 in September. The two-day conference held in London will feature insights from industry leaders, including NVIDIA, and is designed to explore strategic approaches to navigate the next frontier of AI. About IQVIA IQVIA (NYSE:IQV) is a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. IQVIA's portfolio of solutions are powered by IQVIA Connected Intelligence™ to deliver actionable insights and services built on high-quality health data, Healthcare-grade AI ®, advanced analytics, the latest technologies and extensive domain expertise. IQVIA is committed to using AI responsibly, with AI-powered capabilities built on best-in-class approaches to privacy, regulatory compliance and patient safety, and delivering AI to the high standards of trust, scalability and precision demanded by the industry. With approximately 88,000 employees in over 100 countries, including experts in healthcare, life sciences, data science, technology and operational excellence, IQVIA is dedicated to accelerating the development and commercialization of innovative medical treatments to help improve patient outcomes and population health worldwide.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store